KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Guardant Health (GH) Non Operating Income: 2017-2025

Historic Non Operating Income for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -$48,000.

  • Guardant Health's Non Operating Income rose 98.40% to -$48,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.4 million, marking a year-over-year increase of 124.60%. This contributed to the annual value of -$42.6 million for FY2024, which is 180.12% down from last year.
  • As of Q3 2025, Guardant Health's Non Operating Income stood at -$48,000, which was down 92.00% from -$25,000 recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Non Operating Income registered a high of $41.3 million during Q2 2023, and its lowest value of -$29.1 million during Q1 2024.
  • In the last 3 years, Guardant Health's Non Operating Income had a median value of -$48,000 in 2025 and averaged $1.7 million.
  • In the last 5 years, Guardant Health's Non Operating Income tumbled by 9,733.69% in 2022 and then spiked by 10,815.08% in 2023.
  • Quarterly analysis of 5 years shows Guardant Health's Non Operating Income stood at $25.9 million in 2021, then crashed by 79.61% to $5.3 million in 2022, then crashed by 162.79% to -$3.3 million in 2023, then skyrocketed by 240.74% to $4.7 million in 2024, then surged by 98.40% to -$48,000 in 2025.
  • Its Non Operating Income was -$48,000 in Q3 2025, compared to -$25,000 in Q2 2025 and $7.9 million in Q1 2025.